nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of risk factors for long COVID after mild COVID-19 during the Omicron wave in Japan
|
Namie, Hotaka |
|
|
63 |
3 |
p. 303-310 |
artikel |
2 |
A phase 1 study of pembrolizumab plus ipilimumab as first-line treatment in Japanese patients with advanced non-small-cell lung cancer
|
Nogami, Naoyuki |
|
|
63 |
3 |
p. 296-302 |
artikel |
3 |
Challenges in recognizing airway-centered fibrosis: Observer concordance and its role in fibrotic hypersensitivity pneumonitis
|
Seki, Kurumi |
|
|
63 |
3 |
p. 314-321 |
artikel |
4 |
Characteristics of the 11th wave by SARS-CoV-2 KP.3 subvariant: Re-increase in pneumonia severity
|
Miyashita, Naoyuki |
|
|
63 |
3 |
p. 401-404 |
artikel |
5 |
Chronic obstructive pulmonary disease and healthy life expectancy
|
Ogawa, Emiko |
|
|
63 |
3 |
p. 322 |
artikel |
6 |
Clinical interpretation of DLCO and KCO: From rationale to clinical and research applications
|
Yamamoto, Masafumi |
|
|
63 |
3 |
p. 358-364 |
artikel |
7 |
Corrigendum to “Risk factors for interstitial lung disease in patients with non-small cell lung cancer with epidermal growth factor receptor-tyrosine kinase inhibitors: A systematic review and meta-analysis” [Respir Invest, Volume 62, Issue 3, May 2024, Pages 481–487]
|
Fukuda, Yosuke |
|
|
63 |
3 |
p. 467 |
artikel |
8 |
Desaturation after forced vital capacity measurement is suggested diffusing capacity disorder
|
Shimizu, Kohei |
|
|
63 |
3 |
p. 289-295 |
artikel |
9 |
Effect of high fraction of inspired oxygen and high flow on exercise tolerance in patients with COPD and IPF: A randomized crossover trial
|
Chihara, Yuichi |
|
|
63 |
3 |
p. 431-437 |
artikel |
10 |
Efficacy of second line and subsequent treatments of small cell lung cancer with and without immune checkpoint inhibitor combination therapy
|
Morinaga, Daisuke |
|
|
63 |
3 |
p. 423-430 |
artikel |
11 |
Eosinophilic chronic rhinosinusitis as a predictor of super-responder and clinical remission in patients with uncontrolled type 2-high severe asthma treated with biologics
|
Hamada, Satoshi |
|
|
63 |
3 |
p. 247-251 |
artikel |
12 |
Guidance for type 2 inflammatory biomarkers
|
Matsunaga, Kazuto |
|
|
63 |
3 |
p. 273-288 |
artikel |
13 |
Impact of taste changes caused by inhalers on adherence to inhalation therapy among patients with asthma and chronic obstructive pulmonary disease
|
Matsumoto, Takeshi |
|
|
63 |
3 |
p. 252-258 |
artikel |
14 |
Insights on immune profile, pathogenesis and differential diagnosis of hypersensitivity pneumonitis and pulmonary sarcoidosis-A holistic review and bibliometric analysis
|
Dasgupta, Sanjukta |
|
|
63 |
3 |
p. 346-357 |
artikel |
15 |
Key predictors of long-term survival after lung transplantation in Japan
|
Mukai, Shunta |
|
|
63 |
3 |
p. 265-272 |
artikel |
16 |
Letter to the editor: “Factors associated with readmission for community-onset pneumonia among older people: A retrospective study”
|
Mubashirah, Fnu |
|
|
63 |
3 |
p. 422 |
artikel |
17 |
Long-term, real-world effectiveness of biologics for severe uncontrolled asthma: The PROSPECT study
|
Asai, Kazuhisa |
|
|
63 |
3 |
p. 444-452 |
artikel |
18 |
One-minute sit-to-stand test to detect gas exchange capacity during exercise stress in patients with idiopathic or progressive pulmonary fibrosis: A randomized, crossover trial
|
Miyata, Yoshito |
|
|
63 |
3 |
p. 241-246 |
artikel |
19 |
Practical Guidelines for Asthma Management (PGAM): Digest edition
|
Tamaoki, Jun |
|
|
63 |
3 |
p. 405-421 |
artikel |
20 |
Predicting sleep disordered breathing in middle-aged Japanese office workers: A simple and effective screening tool
|
Yamasawa, Wakako |
|
|
63 |
3 |
p. 453-458 |
artikel |
21 |
Prognostic impact of oligometastasis in older patients with extensive-stage small cell lung cancer
|
Morinaga, Daisuke |
|
|
63 |
3 |
p. 373-382 |
artikel |
22 |
Prognostic prediction for newly diagnosed patients with idiopathic interstitial pneumonia: JIPS Registry (NEJ030)
|
Okuda, Ryo |
|
|
63 |
3 |
p. 365-372 |
artikel |
23 |
Renal dysfunction during osimertinib treatment in patients with non–small cell lung cancer positive for EGFR mutations
|
Miyazaki, Yui |
|
|
63 |
3 |
p. 438-443 |
artikel |
24 |
Reply to “Endoscopic reflux esophagitis and decline in pulmonary function in nonsmokers: A retrospective cohort study”
|
Enokido, Takayoshi |
|
|
63 |
3 |
p. 399-400 |
artikel |
25 |
Resting energy expenditure and associated factors are similar in patients with chronic obstructive pulmonary disease and interstitial lung disease
|
Morikawa, Keisuke |
|
|
63 |
3 |
p. 342-345 |
artikel |
26 |
Sarcomatoid pleural mesothelioma evaluated using diffusion-weighted whole-body imaging with background body signal suppression
|
Kinoshita, Ryosuke |
|
|
63 |
3 |
p. 323-325 |
artikel |
27 |
Serum galectin-3 as a biomarker of progression of idiopathic pulmonary fibrosis treated with nintedanib
|
Koga, Yasuhiko |
|
|
63 |
3 |
p. 394-398 |
artikel |
28 |
Successful treatment by switching from benralizumab to dupilumab in a patient with allergic bronchopulmonary mycosis caused by Schizophyllum
commune
|
Motohashi, Takumi |
|
|
63 |
3 |
p. 311-313 |
artikel |
29 |
The clinical impact of acute vasoreactivity testing in patients with severe pulmonary hypertension associated with lung disease: A retrospective exploratory analysis
|
Takano, Ryo |
|
|
63 |
3 |
p. 326-333 |
artikel |
30 |
The 6 Minute Walk Test as a predictor of mortality in idiopathic pulmonary fibrosis: A systematic review
|
Vecchi, Eugenio |
|
|
63 |
3 |
p. 334-341 |
artikel |
31 |
Up-to-date nucleic acid assays for diagnosing respiratory infection
|
Yatera, Kazuhiro |
|
|
63 |
3 |
p. 383-393 |
artikel |
32 |
Utility of serum Krebs von den Lungen-6 and surfactant protein-D levels for the diagnosis of immune checkpoint inhibitor-induced immune-related pneumonitis
|
Nakai, Shogo |
|
|
63 |
3 |
p. 259-264 |
artikel |
33 |
Viscoelastic characteristics of spontaneous sputum obtained from patients with chronic productive cough in comparison to bronchial asthma
|
Ogawa, Haruhiko |
|
|
63 |
3 |
p. 459-466 |
artikel |